Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

236 ARTÍCULOS , VIENDO DEL 181 AL 195

Past, present and future of therapeutic strategies against amyloid-β peptides in Alzheimer's disease: a systematic review

Jeremic D, Jiménez-Díaz L, Navarro-López JD.

Ageing Res Rev. 2021 Dec;72:101496. doi: 10.1016/j.arr.2021.101496. Epub 2021 Oct 21.

The prognostic utility of CSF neurogranin in predicting future cognitive decline in the Alzheimer's disease continuum: A systematic review and meta-analysis with narrative synthesis

Yoong SQ, Lu J, Xing H, Gyanwali B, Tan YQ, Wu XV.

Ageing Res Rev. 2021 Dec;72:101491. doi: 10.1016/j.arr.2021.101491. Epub 2021 Oct 21.

Association of Amyotrophic Lateral Sclerosis and Alzheimer's Disease: New Entity or Coincidence? A Case Series

Vrillon A, Deramecourt V, Pasquier F, Magnin É, Wallon D, Lozeron P, Bouaziz-Amar É, Paquet C.

J Alzheimers Dis. 2021;84(4):1439-1446. doi: 10.3233/JAD-215226.

Cerebrospinal Fluid Biomarker Levels as Markers for Nursing Home Placement and Survival Time in Alzheimer's Disease

Wattmo C, Blennow K, Hansson O.

Curr Alzheimer Res. 2021;18(7):573-584. doi: 10.2174/1567205018666211022164952.

Amyloid and Tau in Alzheimer's Disease: Biomarkers or Molecular Targets for Therapy? Are We Shooting the Messenger?

Kumar A, Nemeroff CB, Cooper JJ, Widge A, Rodriguez C, Carpenter L, McDonald WM.

Am J Psychiatry. 2021 Nov;178(11):1014-1025. doi: 10.1176/appi.ajp.2021.19080873.

A Review of Methods of Diagnosis and Complexity Analysis of Alzheimer's Disease Using EEG Signals

Ouchani M, Gharibzadeh S, Jamshidi M, Amini M.

Biomed Res Int. 2021 Oct 27;2021:5425569. doi: 10.1155/2021/5425569. eCollection 2021.

Effects of exosomal miRNAs in the diagnosis and treatment of Alzheimer's disease

Cui GH, Zhu J, Wang YC, Wu J, Liu JR, Guo HD.

Mech Ageing Dev. 2021 Dec;200:111593. doi: 10.1016/j.mad.2021.111593. Epub 2021 Oct 28.

Transfer Learning for Alzheimer's Disease through Neuroimaging Biomarkers: A Systematic Review

Agarwal D, Marques G, de la Torre-Díez I, Franco Martin MA, García Zapiraín B, Martín Rodríguez F.

Sensors (Basel). 2021 Oct 31;21(21):7259. doi: 10.3390/s21217259.

Association of tear fluid amyloid and tau levels with disease severity and neurodegeneration

Gijs M, Ramakers IHGB, Visser PJ, Verhey FRJ, van de Waarenburg MPH, Schalkwijk CG, Nuijts RMMA, Webers CAB.

Sci Rep. 2021 Nov 22;11(1):22675. doi: 10.1038/s41598-021-01993-x.

Iron Homeostasis Disorder and Alzheimer's Disease

Peng Y, Chang X, Lang M.

Int J Mol Sci. 2021 Nov 18;22(22):12442. doi: 10.3390/ijms222212442.

Tau Biomarkers in Dementia: Positron Emission Tomography Radiopharmaceuticals in Tauopathy Assessment and Future Perspective

Ricci M, Cimini A, Camedda R, Chiaravalloti A, Schillaci O.

Int J Mol Sci. 2021 Nov 30;22(23):13002. doi: 10.3390/ijms222313002.

miRNAs as Therapeutic Tools in Alzheimer's Disease

Lee CY, Ryu IS, Ryu JH, Cho HJ.

Int J Mol Sci. 2021 Dec 1;22(23):13012. doi: 10.3390/ijms222313012.

Molecular Aspects of Cellular Dysfunction in Alzheimer's Disease: The Need for a Holistic View of the Early Pathogenesis

Merlo S, Spampinato SF, Lim D.

Biomolecules. 2021 Dec 1;11(12):1807. doi: 10.3390/biom11121807.

A case report of late-onset schizophrenia differentiated from a dementing disorder

Shimada T, Uehara T, Nagasawa T, Hasegawa M, Maeda Y, Kawasaki Y.

Neurocase. 2021 Dec;27(6):467-473. doi: 10.1080/13554794.2021.2016858. Epub 2021 Dec 23.

YKL-40 as a Potential Biomarker for the Differential Diagnosis of Alzheimer's Disease

Mavroudis I, Chowdhury R, Petridis F, Karantali E, Chatzikonstantinou S, Balmus IM, Luca IS, Ciobica A, Kazis D.

Medicina (Kaunas). 2021 Dec 30;58(1):60. doi: 10.3390/medicina58010060.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias